Shifting the Paradigm to Enable Durable and Effective Cell & Gene Therapies

Vertical NanoStraw growth seen through a Scanning Electron Microscope (SEM)
NAVAN Technologies, Inc. is an enabling technology company commercializing a novel non-viral delivery platform to radically accelerate genetic engineering of human primary cells. The patented NanoStraw technology provides direct intracellular access into hard-to-transfect primary human cells for efficacious delivery of any cargo. By using a physical, non-perturbative mechanism for delivery, the challenges of viral-based cell manufacturing (time, cost and technical difficulties) are eliminated, resulting in fewer, faster operational steps.
Our Vision
Universal Intracellular Access Enables the Broad Promise of Next Generation Cell-Gene Therapies.